Loading
Latest filing published 15 May 2020 for Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.), €177.
No signal scores available.
Only one filing by Kelly Demerino is known so far (15 May 2020): an open-market purchase, €177, in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration